Search results
AstraZeneca’s Fasenra: Approval for asthma may initiate COPD approval
Pharmaceutical Technology via Yahoo Finance· 7 days agoOther KOLs interviewed by GlobalData have expressed a great deal of interest in AstraZeneca’s...
Health Care Roundup: Market Talk
The Wall Street Journal· 2 weeks agoThe Anglo-Swedish pharmaceutical giant’s current full-year targets are 4% below consensus, but an upgrade is likely for later this year, the analysts...
AstraZeneca (AZN) to Report Q1 Earnings: Here's What to Expect
Zacks via Yahoo Finance· 2 weeks agoAstraZeneca’s other drugs, Fasenra, Calquence and newer products, asthma drug Tezspire and lupus...